Skip to Main Content

Paper Details

Results of a Randomized Phase II Trial of Intense Androgen Deprivation Therapy prior to Radical Prostatectomy in Men with High-Risk Localized Prostate Cancer.
J Urol
33
2021
AAPL, Androgen, ERG, Localized Prostate Cancer, Men, PTEN, T3 disease, abiraterone, abiraterone acetate, androgen, apalutamide, intraductal carcinoma, leuprolide, localized prostate cancer, patients, prednisone, prostate cancer, prostate specific antigen, tumor
Author NameAffiliation
Huihui YeUniversity of California Los Angeles
Rosina T LisDana-Farber Cancer Institute
Dana E RathkopfMemorial Sloan Kettering Cancer Center
John K ParsonsUniversity of California San Diego
Mark M PomerantzDana-Farber Cancer Institute
Mark M PomerantzDana-Farber Cancer Institute
Mary-Ellen TaplinDana-Farber Cancer Institute
  • 1 - 7

Datasets

Release 1.2